Bone Marrow TransplantationTransplantation, HomologousGraft vs Host DiseaseBone MarrowWhole-Body IrradiationBone Marrow CellsLeukemiaAnemia, AplasticTransplantation ConditioningTransplantation, AutologousTransplantation ChimeraBusulfanTissue DonorsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveGraft SurvivalLeukocyte TransfusionHistocompatibility TestingHematopoietic Stem Cell TransplantationGraft vs Tumor EffectRecurrenceHistocompatibilityRadiation ChimeraLeukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-LymphomaGraft vs Host ReactionCyclophosphamideLymphocyte DepletionRemission InductionHematologic NeoplasmsGraft vs Leukemia EffectTransplantation, IsogeneicBone and BonesAcute DiseaseLymphocyte TransfusionHepatic Veno-Occlusive DiseaseImmunosuppressive AgentsLeukemia, MyeloidBone Marrow PurgingMice, Inbred C57BLCombined Modality TherapyHematopoietic Stem CellsChimeraImmunosuppressionT-LymphocytesMyelodysplastic SyndromesTime FactorsTreatment OutcomeNuclear FamilyLiver TransplantationHematopoiesisTransplantation ImmunologyCyclosporineGraft RejectionActuarial AnalysisSurvival AnalysisHLA AntigensCytomegalovirus InfectionsRetrospective StudiesHematologic DiseasesFatal OutcomeMice, Inbred BALB CLymphoma, Non-HodgkinSevere Combined ImmunodeficiencyCytarabineBone Marrow DiseasesSurvival RateKidney TransplantationAntineoplastic Combined Chemotherapy ProtocolsDisease-Free SurvivalFollow-Up StudiesSpleenPancytopeniaLeukocyte CountGranulocyte Colony-Stimulating FactorLeukemia, Myelomonocytic, AcuteAnemia, Refractory, with Excess of BlastsInfectionStem Cell TransplantationBone Marrow ExaminationMethotrexateLymphomaEtoposideNeoplasm, ResidualCyclosporinsGanciclovirMultiple MyelomaImmunocompromised HostAntilymphocyte SerumFlow CytometryBone RemodelingPrognosisMice, Inbred AKRColony-Forming Units AssayImmunophenotypingMice, Inbred C3HCytogeneticsPneumonia, ViralBone Marrow NeoplasmsMinor Histocompatibility AntigensThymus Gland